MetLife (NYSE:MET) Price Target Raised to $113.00

MetLife (NYSE:MET – Get Free Report) had its target price raised by analysts at Wells Fargo & Company from $110.00 to $113.00 in a report issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 9.74% from the stock’s current price.

A number of other research analysts have also issued reports on MET. Piper Sandler increased their target price on shares of MetLife from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Monday. Argus lifted their price target on shares of MetLife from $93.00 to $109.00 and gave the company a “buy” rating in a research report on Wednesday, September 2nd. Mizuho boosted their price target on MetLife from $112.00 to $117.00 and gave the company an “outperform” rating in a research note on Thursday. Jefferies Financial Group increased their price target on MetLife from $103.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Finally, Keefe, Bruyette & Woods raised their price objective on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 11th. Fourteen analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, MetLife currently has an average rating of “Moderate Buy” and a consensus price target of $107.12.

Get Our Latest Research Report on MetLife

MetLife Price Performance

NYSE:MET opened at $102.97 on Thursday. MetLife has a 12-month low of $67.33 and a 12-month high of $106.72. The firm has a market capitalization of $64.71 billion, a price-to-earnings ratio of 13.43, a P/E/G ratio of 0.97 and a beta of 0.79. The stock’s 50 day moving average price is $98.57 and its two-hundred day moving average price is $86.65. The company has a quick ratio of 0.20, a current ratio of 0.21 and a debt-to-equity ratio of 0.65.

MetLife (NYSE:MET – Get Free Report) last announced its earnings results on Wednesday, November 4th. The financial services provider reported $2.78 EPS for the quarter, topping the consensus estimate of $2.77 by $0.01. MetLife had a net margin of 6.21% and a return on equity of 25.71%. The business had revenue of $20.52 billion during the quarter, compared to the consensus estimate of $19.86 billion. During the same quarter in the previous year, the firm posted $2.34 EPS. MetLife’s revenue was up 18.2% compared to the same quarter last year. On average, analysts anticipate that MetLife will post 9.94 earnings per share for the current year.

MetLife announced that its Board of Directors has initiated a share repurchase program on Wednesday, August 5th that permits the company to buy back $3 billion in shares. This buyback authorization permits the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On MetLife

Hedge funds and other institutional investors have recently made changes to their positions in the company. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of MetLife during the 2nd quarter worth approximately $26,000. Burk Holdings LLC bought a new position in MetLife in the second quarter valued at approximately $27,000. Nvwm LLC raised its position in MetLife by 655.3% during the third quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 249 shares in the last quarter. Highland Investment Advisors LLC acquired a new position in MetLife during the second quarter valued at approximately $30,000. Finally, Meeder Asset Management Inc. raised its position in MetLife by 156.5% during the third quarter. Meeder Asset Management Inc. now owns 354 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 216 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Company Profile

(Get Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Further Reading

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.